Astec LifeSciences IPO
Astec LifeSciences IPO — date, price band, lot size & details 2009
Astec LifeSciences listed on 25 Nov 2009 at ₹83, 1.2% above the ₹82 issue price.
Astec LifeSciences is a Mumbai based maker of off patent agrochemical and pharmaceutical intermediates, active ingredients and formulations. Its total income was Rs 93.72 crore in FY2009.
Stock price
Astec LifeSciences is listed — here is the live share price.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Timetable
Key dates from opening to listing. Today is 12 November.
- Open 29 Oct 2009
- Close 04 Nov 2009
- Allotment 17 Nov 2009
- Refund/credit TBA
- Listing 25 Nov 2009
Issue summary
The terms of the offer, as filed.
| IPO Dates | 29 Oct to 4 Nov, 2009 |
|---|---|
| Price Band | ₹77 – ₹82 |
| Face Value | ₹10 |
| Lot Size | 75 Shares |
| Issue Size | ₹61.5 Cr |
| Sale Type | Fresh capital only |
| Listing On | BSE, NSE |
| Registrar | Bigshare Services Private Limited |
| Min Investment | ₹ 6,150 |
Share of the offer set aside for each investor category, as stated in the offer document.
What will it cost me?
Bidding is in multiples of 75 shares at the ₹82 cut-off. Drag to size your application.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 75 | ₹6,150 |
| Retail (max) | 32 | 2,400 | ₹1,96,800 |
| S-HNI (min) | 33 | 2,475 | ₹2,02,950 |
| S-HNI (max) | 162 | 12,150 | ₹9,96,300 |
| B-HNI (min) | 163 | 12,225 | ₹10,02,450 |
Strengths & risks
Drawn from the offer document — the case for and against, side by side.
Strengths · 4
- 01Total income rose from Rs 33.51 crore in FY2007 to Rs 93.72 crore in FY2009.
- 02Profit after tax rose from Rs 3.62 crore in FY2007 to Rs 10.72 crore in FY2009.
- 03EBITDA rose from Rs 6.44 crore in FY2007 to Rs 21.66 crore in FY2009.
- 04Return on net worth was 35.15%.
Risks · 5
- 01Total borrowing rose from Rs 23.07 crore in FY2007 to Rs 40.34 crore in June 2009, more than its net worth of Rs 33.95 crore.
- 02Agrochemical demand depends on the monsoon and farm incomes; total income was Rs 27.48 crore in the June 2009 quarter.
- 03Off patent products face competition from many makers; Rs 3.76 crore of the issue was for product registrations.
- 04Rs 32.56 crore of the issue was for expanding its Mahad plants.
- 05Promoter holding fell from 99.99% before the issue to 55.69% after it.
Three years of numbers
All figures in ₹ crore, as reported in the Astec LifeSciences offer document.
| Metric | 30 Jun 2009 | 31 Mar 2009 | 31 Mar 2008 | 31 Mar 2007 |
|---|---|---|---|---|
| Assets | 98.17 | 95.90 | 77.21 | 52.01 |
| Total Income | 27.48 | 93.72 | 61.09 | 33.51 |
| Profit After Tax | 3.43 | 10.72 | 7.93 | 3.62 |
| EBITDA | 6.68 | 21.66 | 15.72 | 6.44 |
| NET Worth | 33.95 | - | 21.38 | 14.42 |
| Reserves and Surplus | 25.79 | 22.36 | 12.82 | 14.14 |
| Total Borrowing | 40.34 | 43.83 | 32.94 | 23.07 |
See how this IPO compares — view listing performance of all mainboard IPOs.
Valuation & key ratios
Ratios are for the latest full financial year reported in the Astec LifeSciences RHP.
Where the money goes
₹64.50 Cr of the issue is earmarked to named objects.
About the company
It makes and sells intermediates, active ingredients and formulations in the off patent proprietary category, focused on the agrochemical and pharmaceutical industries.
It had three units in Maharashtra, one at Dombivli and two at Mahad. It started in August 1994 by buying a sick unit at Dombivli with a capacity of 120 MT.
The IPO was Rs 61.5 crore and was entirely a fresh issue at Rs 82, the top of the Rs 77 to Rs 82 band. The money was mainly for expanding its Mahad plants and research facility, and product registrations.
Interested in this IPO? Check the live subscription status or browse all upcoming mainboard IPOs.
The bankers & the filings
Who is running the book, and the documents this page is built from.
Astec LifeSciences IPO Documents
Read the filings this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
IDBI Capital Markets & Securities Ltd.
42 issues handledBest listing: Route Mobile (+104.9%). Weakest: Bharat Dynamics (-13.6%).
Almondz Global Securities Ltd
23 issues handledBest listing: Amar Remedies (+100.0%). Weakest: First Winner Industries (-12.0%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Company contact
Frequently asked
What is the GMP of Astec LifeSciences?
The current Grey Market Premium is ₹0.
What is the Astec LifeSciences IPO price band?
₹77 to ₹82, on a face value of ₹10.
When is the allotment?
The basis of allotment is 17 November 2009, with listing on 25 November 2009.
How do I check allotment status?
On the IPO Guru allotment page or on the registrar's site — Bigshare Services Private Limited.
Every number here traces back to a filing.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Every number on this page is sourced from the RHP, BSE & NSE.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
